Folgen
Ana Nordberg
Ana Nordberg
Associate Professor, Senior Lecturer, Faculty of Law, Lund University, Sweden
Bestätigte E-Mail-Adresse bei jur.lu.se - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Cutting edges and weaving threads in the gene editing (Я) evolution: reconciling scientific progress with legal, ethical, and social concerns
A Nordberg, T Minssen, S Holm, M Horst, K Mortensen, BL Møller
Journal of Law and the Biosciences 5 (1), 35-83, 2018
612018
Large expert-curated database for benchmarking document similarity detection in biomedical literature search
P Brown, AC Tan, MA El-Esawi, T Liehr, O Blanck, DP Gladue, ...
Database 2019, 2019
362019
Regulating germline editing in assisted reproductive technology: An EU cross‐disciplinary perspective
A Nordberg, T Minssen, O Feeney, I de Miguel Beriain, L Galvagni, ...
Bioethics 34 (1), 16-32, 2020
132020
Biobank and biomedical research: responsibilities of controllers and processors under the EU General Data Protection Regulation
A Nordberg
GDPR and Biobanking: Individual Rights, Public Interest and Research …, 2021
122021
A “Ray of Hope” for European Stem Cell Patents or “Out of the Smog into the Fog”? An Analysis of Recent European Case Law and How it Compares to the US
A Nordberg, T Minssen
IIC-International Review of Intellectual Property and Competition Law 47 …, 2016
122016
The Evolution of the CJEU's Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
T Minssen, A Nordberg
Published in Nordic Intellectual Property Law Review (NIR), 493-503, 2015
112015
The Impact of “Broccoli II” and “Tomatoes II” on European Patents in Conventional Breeding, GMOs, and Synthetic Biology: The Grand Finale of a Juicy Patents Tale?
T Minssen, A Nordberg
Biotechnology Law Report 34 (3), 81-98, 2015
102015
Trade secrets, big data and artificial intelligence innovation: a legal oxymoron?
A Nordberg
The Harmonization and Protection of Trade Secrets in the EU, 192-218, 2020
82020
CoViD-19 pandemic in Sweden: measures, policy approach and legal and ethical debates
A Nordberg, T Mattsson
Biolaw Journal-Rivista Di Biodiritto, 731-739, 2020
82020
EU design law and 3D printing: finding the right balance in a new E-ecosystem
A Nordberg, J Schovsbo
3D Printing, Intellectual Property and Innovation–Insights from Law and …, 2016
82016
Rules and Tools in the Battle Against Superbugs—A Call for Integrated Strategies and Enhanced International Collaboration to Promote Antimicrobial Drug Development
T Minssen, A Nordberg
Infectious Diseases in the New Millennium: Legal and Ethical Challenges, 111-136, 2020
52020
Patentability of methods of human enhancement
A Nordberg
Journal of Intellectual Property Law & Practice 10 (1), 19-28, 2015
42015
Governing, protecting, and regulating the future of genome editing: the significance of ELSPI perspectives
S Slokenberga, T Minssen, A Nordberg
Brill, 2023
32023
Balancing innovation,‘ordre public’and morality in human germline editing: A call for more nuanced approaches in patent law
D Matthews, T Minssen, A Nordberg
European Journal of Health Law 29 (3-5), 562-588, 2022
32022
Sweden: Legal response to Covid-19
T Mattsson, A Nordberg, M Axmin
Oxford University Press, 2021
32021
Legal method and interpretation in international IP law: pluralism or systemic coherence
A Nordberg
Is Intellectual Property Pluralism Functional?, 96-127, 2019
32019
Defining Human Enhancement: towards a foundational conceptual tool for Enhancement Law
A Nordberg
Journal of Law, Information & Science 25 (3), 2017
3*2017
Genome editing in humans: A survey of law, regulation and governance principles
A Nordberg
Panel for the Future of Science and Technology (STOA), European Parliament, 2022
22022
The role of patents and licensing in the governance of human genome editing: a white paper
D Matthews, A Brown, E Gambini, T Minssen, A Nordberg, JS Sherkow, ...
Queen Mary Law Research Paper, 2021
22021
Patentability of human enhancement: from ethical dilemmas to legal (un) certainty
A Nordberg
Intellectual Property Perspectives on the Regulation of New Technologies, 54-92, 2018
22018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20